$ACN is a publicly traded company in the Government Operations and Politics sector. This company operates across Government Operations and Politics and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 16 active Congressional signals mentioning $ACN, including 6 bills and 10 federal contracts. The current legislative sentiment is predominantly bullish, suggesting potential tailwinds from government policy.
The ZOMBIE Act (HR8467) is a procedural government operations bill that amends the Payment Integrity Information Act of 2019 to tighten definitions and reporting requirements around improper payments resulting in financial loss to the government. It does not authorize or appropriate any new spending, create new programs, or directly affect any publicly traded company's revenue or operations. The bill passed out of committee unanimously (40-0) but has no direct market impact.
Accenture Federal Services LLC, a subsidiary of Accenture ($ACN), secured an $11.9M contract renewal from the Social Security Administration for Hyperscience licenses and support. This contract represents a recurring revenue stream for Accenture and Hyperscience, a private company, supporting critical government operations.
Accenture Federal Services LLC, a subsidiary of Accenture plc ($ACN), secured a $12.0 million BPA Call from the FBI for EPAS Services. This contract represents a negligible portion of Accenture's annual revenue and is a routine award for IT services.
This $12.3M contract to Chickasaw Aerospace, LLC for FDA IT services is a routine award for modernizing adverse event monitoring, with minimal direct impact on major publicly traded companies. However, it signals ongoing federal investment in healthcare IT infrastructure, benefiting larger players in the sector.
Accenture Federal Services LLC, a subsidiary of Accenture ($ACN), secured a $20.2 million Blanket Purchase Agreement (BPA) for CIO Business Operations Support Services with the Department of Energy. While a steady revenue stream, this contract represents a minor percentage of Accenture's overall revenue, suggesting a neutral impact on its stock performance.
Accenture Federal Services LLC, a subsidiary of Accenture ($ACN), secured a $20.8 million BPA call from the Department of Energy for CIO business operations support. This contract represents a routine, yet significant, award for Accenture's federal division, contributing to its consistent revenue stream in government IT services.
This $27.9 million BPA Call to VIATRIE LLC for IT advisement support at the USDA is a routine operational contract, unlikely to have a direct, significant impact on publicly traded companies or their stock performance due to VIATRIE LLC being a private entity and the contract's specific nature.
Deloitte & Touche LLP, a private entity, secured a $66.8 million contract from the Department of Veterans Affairs for cybersecurity transformation. This award highlights continued federal investment in digital infrastructure for healthcare, benefiting publicly traded competitors like Accenture ($ACN) and IBM ($IBM) in the long term.
Accenture Federal Services LLC, a subsidiary of Accenture plc, secured a $70.5 million BPA call from the Department of State for IT services. This contract represents a routine, yet significant, revenue stream for Accenture's federal division, contributing approximately 0.12% to its annual revenue.
This $150M contract award to Four Points Technology for AWS Connect services directly benefits Amazon ($AMZN) as the underlying cloud provider, representing a significant expansion of cloud-based contact center solutions within the Social Security Administration.
Accenture Federal Services LLC, a subsidiary of Accenture ($ACN), secured a $153 million contract from the Department of Education for TIVOD systems and customer service transition services. This award represents approximately 0.25% of Accenture's annual revenue, indicating a routine but solid win for its federal division.
S.1956 is an early-stage, unfunded mandate requiring federal agencies to assess their software assets. It creates a bounded, short-term consulting opportunity for IT services firms like ACN and CDW, but the lack of new appropriations limits the financial impact. Real market data confirms the bill has zero pricing signal — ACN, IBM, ORCL, and MSFT moved on broader tech rotation, not this legislation.
HR6329 is an early-stage, pre-appropriation procedural bill requiring OMB to update federal data quality guidelines. It authorizes zero direct funding and creates a low-single-digit-million-dollar consulting opportunity for federal IT advisory firms. All four tracked tickers declined over the past 7 days, consistent with the bill's lack of material revenue catalyst. No near-term market impact.
S.4098 (AI-Ready Data Act) is an early-stage Senate bill that directs NIST to develop standards for making open government data AI-ready. No funding is authorized, and the bill sits in committee with only one cosponsor and two legislative actions since March 2026. Passage probability is low in its current form, limiting near-term market impact. Winners would be federal IT consultants and systems integrators like Accenture ($ACN) and IBM ($IBM) if momentum builds.
HR1910 (Chief Risk Officer Enforcement and Accountability Act) is an early-stage bill that codifies existing Fed CRO regulations for large banks, with the structural change of extending requirements to privately held large banks. Publicly traded mega-banks (JPM, BAC, WFC, C, MS, GS) already comply — no new costs. The bill creates incremental demand for compliance consulting and software vendors like ACN, IBM, and ORCL but is in early committee stage with low passage probability.
The Climate Change Financial Risk Act of 2025 (HR2823) would impose mandatory biennial climate risk capital evaluations and resolution plans on large U.S. banks. This creates direct compliance costs for JPMorgan, Bank of America, Citigroup, Goldman Sachs, and Morgan Stanley, while generating demand for consulting and IT services from Accenture and IBM. The bill is in early legislative stages with a companion bill in the Senate, but has low near-term passage probability given partisan dynamics and its early committee referral status.